CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Goldman Sachs “Healthcare CEOs Unscripted: A View from the Top” conference on Tuesday, January 5, 2015 at 1:00 pm ET at the InterContinental Hotel in Boston.
